Melanotan II
Melanocortin Receptor AgonistresearchAlso known as: MT-2, MT-II, Melanotan 2
A synthetic cyclic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that induces skin tanning, increases libido, and reduces appetite through melanocortin receptor activation.
Overview
Melanotan II is a synthetic cyclic heptapeptide analogue of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH). Originally developed at the University of Arizona in the 1990s for the prevention of skin cancer by stimulating melanogenesis (skin darkening) without UV exposure, it was found to have potent sexual arousal and appetite-suppressing side effects. Melanotan II acts as a non-selective agonist at melanocortin receptors MC1R through MC5R, which accounts for its broad range of effects. Its tanning properties are mediated through MC1R activation on melanocytes, while its pro-sexual effects are primarily through MC3R and MC4R in the central nervous system. The closely related compound PT-141 (bremelanotide) was derived from Melanotan II research and is now FDA-approved for hypoactive sexual desire disorder in women. Melanotan II itself remains unapproved and is widely used in the tanning and biohacking communities despite safety concerns, particularly regarding its non-selective receptor activation and potential for promoting melanocytic nevi (moles) growth.
Mechanism of Action
Melanotan II acts as a non-selective agonist at melanocortin receptors (MC1R–MC5R): (1) MC1R activation on melanocytes stimulates eumelanin production, causing skin darkening without UV exposure; (2) MC3R and MC4R activation in the hypothalamus modulates sexual arousal pathways, increasing libido and erectile function; (3) MC4R activation in the hypothalamus suppresses appetite through POMC/AgRP neuronal circuits; (4) MC3R/MC4R activation modulates energy homeostasis and fat metabolism; (5) The cyclic structure provides enhanced metabolic stability and receptor binding affinity compared to linear α-MSH; (6) Crosses the blood-brain barrier to exert central nervous system effects.
Molecular Formula
C50H69N15O9
Molecular Weight
1024.18 g/mol
Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
Dosage Protocols
Dose Range
250mcg – 500mcg
Frequency
Once daily
Route
subcutaneous
Cycle Length
Loading: daily for 2-3 weeks, then 1-2x per week maintenance
Start with a low dose (100-250mcg) to assess tolerance due to common nausea. Minimal UV exposure enhances and accelerates tanning. Loading phase builds melanin, maintenance sustains it.
Source: Community protocols
🧮 Personalized Dosage Calculator
💰 Estimated Pricing
Typical Supply
10mg vial
Last Updated
2026-02
Tanning/libido peptide. Very affordable from research vendors: $15-35. Not FDA-approved. Popular but carries risks (moles, nausea).
⚠️ Prices are estimates based on publicly available data and may vary significantly by vendor, location, and prescription status. This is not medical or financial advice.
Side Effects
| Effect | Severity |
|---|---|
| Nausea | moderate |
| Facial flushing | mild |
| Spontaneous erections | mild |
| Darkening of existing moles | moderate |
| Appetite suppression | mild |
| Fatigue / Drowsiness | mild |
| Injection site reactions | mild |
| Increased blood pressure | moderate |
Pros & Cons
Provides effective skin darkening with minimal or no UV exposure, potentially reducing UV-related skin damage
Strong pro-sexual effects including increased libido and improved erectile function in both sexes
Appetite suppression can aid in weight management goals
Once tanning is established, infrequent maintenance dosing is sufficient
Non-selective melanocortin receptor activation causes a wide range of off-target effects
May promote growth or darkening of existing moles, with theoretical concern for melanoma in predisposed individuals
Significant nausea is very common, especially at initiation
Not approved for human use in any country; quality control of research products is variable
Long-term safety data in humans is lacking
Research Studies
🩸 Blood Work
Blood Pressure (baseline reading)
Melanocortin agonist can affect blood pressure
Liver Function Panel (AST/ALT)
Hepatic processing of melanocortin peptides
Kidney Function (BMP/CMP)
General organ function baseline
Skin Cancer Screening
Stimulates melanogenesis — existing moles/nevi should be evaluated
Hormone Panel (Testosterone, Estradiol)
MT-II has broad melanocortin activity affecting multiple hormones
Non-selective melanocortin agonist — affects skin pigmentation, appetite, libido, and blood pressure. Dermatological screening is important as it can darken existing moles, making melanoma harder to detect. NOT FDA-approved.
Legal Status
Not FDA-approved. Available as a research chemical. Illegal to sell for human consumption in many countries including Australia and the UK. Banned by WADA. PT-141, a derivative, is FDA-approved for female HSDD.
💬 Community Experiences
Share Your ExperienceAchieved a deep, even tan with minimal sun exposure. Started with a loading phase and now on maintenance. Nausea was rough during loading — ginger helps. Results are undeniable.
Works for tanning but the side effects are notable — nausea, facial flushing, and increased mole activity that I'm monitoring. Use with caution and get skin checks.
Effective but I stopped due to new moles appearing. Not worth the skin cancer risk for me personally. If you use this, please get regular dermatology checkups.
⚠️ Individual experiences may vary. These are user-submitted reports for informational purposes only. Always consult a healthcare professional before starting any peptide protocol.
Readers Also Viewed
Semaglutide
99An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
98A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
97A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
95The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.
Related Peptides
CJC-1295 + Ipamorelin (Combo)
The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.
Collagen Peptides
Bioactive peptide fragments derived from hydrolyzed collagen protein that support skin elasticity, joint health, bone density, hair/nail growth, and gut lining integrity through stimulation of endogenous collagen synthesis.
Ipamorelin
A highly selective growth hormone-releasing peptide (GHRP) that stimulates GH release with minimal impact on cortisol, prolactin, or appetite, making it the cleanest GHRP available.
MK-677 (Ibutamoren)
An orally active, non-peptide growth hormone secretagogue that mimics ghrelin to raise GH and IGF-1 levels for up to 24 hours per dose, with notable effects on sleep, appetite, and body composition.